InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by NEUPERT PETER M, Director. Officer active across 2 companies, notably Adaptive Biotechnologies Corp. Cumulatively, 6 filings have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €602k. Activity tracked since 26 January 2022. The latest transaction was disclosed on 16 February 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
1,300 shares@ US$262.850.0015% mcap50.0% of flowCommon StockSEC:0001127602-22-005820:0
Ideal exit: 13 Nov 2022 (T+270)
1,300 shares@ US$262.850.0015% mcap100.0% of flowCommon StockSEC:0001127602-22-005820
Ideal exit: 13 Nov 2022 (T+270)
771 sharesCommon StockSEC:0001127602-22-003412:0
771 sharesCommon StockSEC:0001127602-22-003412
6,689 shares0Common StockSEC:0001209191-22-005495:0
6,689 shares0Common StockSEC:0001209191-22-005495
6 of 6 declarations
About NEUPERT PETER M
Peter M. Neupert is a Board Member at Adaptive Biotechnologies Corp and Laboratory Corp of America Holdings. He brings his expertise in biotechnology and healthcare, contributing to governance and strategy for both companies.
